Article Text
Letters to the editor
Contraceptive options for women with SLE
Statistics from Altmetric.com
May I congratulate the authors of the commentary describing contraceptive options for women with systemic lupus erythematosis (SLE).1 This was a comprehensive summary and I was interested in their views regarding the suitability of progestogen-only methods in women with antiphospholipid antibodies. The authors felt these methods were unsafe in such …
Footnotes
-
Competing interests The author has received financial support to attend pharmaceutical advisory board meetings, undertake research studies, speak at educational meetings and conferences along with travel grants from Astellas, Bayer, Consilient Healthcare, HRA Pharma, Merck, Pfizer and Vifor Pharma.